Detection of circulating tumor DNA in early-and late-stage human malignancies
C Bettegowda, M Sausen, RJ Leary, I Kinde… - Science translational …, 2014 - science.org
The development of noninvasive methods to detect and monitor tumors continues to be a
major challenge in oncology. We used digital polymerase chain reaction–based …
major challenge in oncology. We used digital polymerase chain reaction–based …
Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology
Adenocarcinoma of the endometrium (also known as endometrial cancer, or more broadly
as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the …
as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the …
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers
Papanicolaou (Pap) smears have revolutionized the management of patients with cervical
cancers by permitting the detection of early, surgically curable tumors and their precursors …
cancers by permitting the detection of early, surgically curable tumors and their precursors …
NCCN guidelines insights: cervical cancer, version 1.2020: featured updates to the NCCN guidelines
NR Abu-Rustum, CM Yashar, S Bean, K Bradley… - Journal of the National …, 2020 - jnccn.org
The NCCN Guidelines for Cervical Cancer provide recommendations for diagnostic workup,
staging, and treatment of patients with the disease. These NCCN Guidelines Insights focus …
staging, and treatment of patients with the disease. These NCCN Guidelines Insights focus …
NCCN GuidelinesŪ Insights: Uterine Neoplasms, Version 3.2021: Featured Updates to the NCCN Guidelines
NR Abu-Rustum, CM Yashar, K Bradley… - Journal of the National …, 2021 - jnccn.org
The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic
workup, clinical staging, and treatment options for patients with endometrial cancer or …
workup, clinical staging, and treatment options for patients with endometrial cancer or …
Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity
RL Giuntoli, TJ Webb, A Zoso, O Rogers… - Anticancer …, 2009 - ar.iiarjournals.org
Background: To identify immunosuppressive elements present in ovarian cancer associated
ascites. Patients and Methods: Ascites and plasma were obtained from ovarian, primary …
ascites. Patients and Methods: Ascites and plasma were obtained from ovarian, primary …
Cervical cancer
WJ Koh, BE Greer, NR Abu-Rustum, SM Apte… - Journal of the National …, 2013 - jnccn.org
These NCCN Clinical Practice Guidelines in Oncology for Cervical Cancer focus on early-
stage disease, because it occurs more frequently in the United States. After careful clinical …
stage disease, because it occurs more frequently in the United States. After careful clinical …
[PDF][PDF] Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range
A Santillan, R Garg, ML Zahurak… - Journal of Clinical …, 2005 - researchgate.net
Risk of Epithelial Ovarian Cancer Recurrence in Patients With Rising Serum CA-125 Levels
Within the Normal Range Page 1 Risk of Epithelial Ovarian Cancer Recurrence in Patients With …
Within the Normal Range Page 1 Risk of Epithelial Ovarian Cancer Recurrence in Patients With …
Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome
R Salani, A Santillan, ML Zahurak… - … Journal of the …, 2007 - Wiley Online Library
BACKGROUND. The objective of this study was to evaluate the role of secondary
cytoreductive surgery in the outcome of patients who had recurrent epithelial ovarian …
cytoreductive surgery in the outcome of patients who had recurrent epithelial ovarian …
Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes
RE Bristow, ML Zahurak, TP Diaz-Montes… - Gynecologic …, 2009 - Elsevier
OBJECTIVE: To evaluate the impact of surgeon and hospital case volume, and other related
variables, on short-term outcomes after surgery for ovarian cancer. METHODS: The …
variables, on short-term outcomes after surgery for ovarian cancer. METHODS: The …